Drug metabolism in human liver S9 fraction treated with 50 uM of lenvatinib up to 120 mins by HPLC analysis in presence of GSH and absence of NADPH

Basic Information

ID: ALA3536183

Type: ADME

Description: Drug metabolism in human liver S9 fraction treated with 50 uM of lenvatinib up to 120 mins by HPLC analysis in presence of GSH and absence of NADPH

Format: BAO_0000019

Organism: Homo sapiens

Tissue: Liver

Target:  ADMET(ALA612558)

Document:  ALA3526157

Drug metabolism in human liver S9 fraction treated with 50 uM of lenvatinib up to 120 mins by HPLC analysis in presence of GSH and absence of NADPH: 1

Activity Charts

Compound Summary

Parent Molecular WeightALogPPolar Surface Area
507.53-0.69-0.69